Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Eton Pharmaceuticals' Other Accumulated Expenses history spans 3 years, with the latest figure at $675000.0 for Q1 2025.

  • For Q1 2025, Other Accumulated Expenses changed N/A year-over-year to $675000.0; the TTM value through Mar 2025 reached $675000.0, changed N/A, while the annual FY2023 figure was $5.4 million, N/A changed from the prior year.
  • Other Accumulated Expenses for Q1 2025 was $675000.0 at Eton Pharmaceuticals, down from $4.9 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $5.4 million in Q4 2023 and bottomed at $675000.0 in Q1 2025.
  • The 3-year median for Other Accumulated Expenses is $4.9 million (2024), against an average of $3.6 million.